CompletedNCT00712699
Extended-release amphetamine or placebo for preschool ADHD
About this title
Read the official source — NCT00712699Medication studyAges 36–66 months
Understand this study
Who was this study for?
Listed age limits: 36 months to 66 months.
- Participation duration
- 6 weeks
Study information
Study start dateJune 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 27
- Sponsor
- Baystate Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Locations
- Not clearly listed
- Age range
- From 36 Months to 66 Months
- Official registry ID
- NCT00712699
- Official title
Show the full official title
Placebo vs. Extended Release Stimulant Crossover Trial in Preschoolers With ADHD
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Locations not listed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Baystate Medical Center, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Sequence 1: XR-MAS then placebo and Sequence 2 Placebo then XR-MAS.
Who was this study for?
Listed age limits: 36 months to 66 months.
